Atara Biotherap (ATRA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2019 | 06-2019 | 03-2019 | 12-2018 | 09-2018 | |
| Operating Expenses | 72,556 | 75,535 | 67,891 | 81,816 | 60,220 |
| Operating Income | -72,556 | -75,535 | -67,891 | -81,816 | -60,220 |
| Other Income | 661 | 1,207 | 1,634 | 1,757 | 1,859 |
| Pre-tax Income | -71,895 | -74,328 | -66,257 | -80,059 | -58,361 |
| Income Tax | N/A | N/A | N/A | -47 | N/A |
| Net Income Continuous | -71,895 | -74,328 | -66,257 | -80,012 | -58,361 |
| Net Income | $-71,895 | $-74,328 | $-66,257 | $-80,012 | $-58,361 |
| EPS Basic Total Ops | -32.75 | -40.00 | -36.00 | -44.50 | -32.25 |
| EPS Basic Continuous Ops | -32.73 | -40.03 | -35.91 | -44.68 | -32.13 |
| EPS Diluted Total Ops | -32.75 | -40.00 | -36.00 | -44.50 | -32.25 |
| EPS Diluted Continuous Ops | -32.73 | -40.03 | -35.91 | -44.68 | -32.13 |
| EBITDA(a) | $-71,127 | $-74,157 | $-66,701 | $-80,884 | $-59,613 |